Search results for "Behcet Syndrome"

showing 10 items of 24 documents

Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation an…

2010

Introduction: Infliximab is a chimeric monoclonal antibody against tumor necrosis factor alpha (TNF-α) that has been introduced recently for Behcet's disease (BD) patients who were resistant to standard treatment. The aim of this study was to analyse the functional changes of Vγ9/Vδ2 T lymphocytes in both active and inactive disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicity. Methods: We investigated 1) cell expansion, 2) expression of TNFRII receptor, 3) perforin and gamma interferon (IFN) content, 4) release of granzyme A (GrA) and 5) phenotype changes, in vitro and in vivo, in Vγ9/Vδ2 T lymphocytes by means of fluorescence-activated cell sorter …

AdultAdolescentCell SurvivalT cellLymphocyteT-LymphocytesImmunologyGranzymesInterferon-gammaYoung AdultRheumatologyAntigenmedicineImmunology and AllergyHumansReceptors Tumor Necrosis Factor Type IIInterferon gammaCells CulturedAgedCell ProliferationbiologyPerforinBehcet SyndromeAntibodies MonoclonalReceptors Antigen T-Cell gamma-deltaMiddle AgedInfliximabmedicine.anatomical_structurePhenotypeGranzymePerforinAntirheumatic AgentsCase-Control StudiesImmunologybiology.proteinGranzyme ATumor necrosis factor alphaFemalemedicine.drugResearch ArticleArthritis Research & Therapy
researchProduct

PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease

2010

OBJECTIVES: To investigate potential associations between the PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA (GpIIIa) gene and venous thrombosis and other clinical manifestations in Italian patients with Behçet's disease (BD). METHODS: Two hundred consecutive Italian patients satisfying the International Study Group criteria for BD who were followed up for seven years and 241 healthy Italian age- and gender-matched blood donors were molecularly genotyped for the PlA1/A2 polymorphism of the platelet GpIIIa gene; 118 and 117 of the 200 BD patients were also respectively genotyped for factor V Leiden and prothrombin gene G20210A polymorphisms. A standard microlymphocytotoxicit…

AdultBlood PlateletsMaleVenous ThrombosisPolymorphism GeneticAdolescentGenotypeBehcet SyndromeIntegrin beta3Factor VPLA1/2 polymorphism Behcet's diseaseYoung AdultHuman PlateletGene FrequencyGeneticHumansAntigens Human PlateletFemaleProthrombinAdolescent; Adult; Antigens Human Platelet; Blood Platelets; Factor V; Female; Gene Frequency; Genotype; Humans; Integrin beta3; Male; Polymorphism Genetic; Prothrombin; Young Adult; Behcet Syndrome; Venous ThrombosisAntigensPolymorphism
researchProduct

THE LEVEL OF SOLUBLE GRANZYME A IS ELEVATED IN THE PLASMA AND IN THE Vgamma9/Vdelta2 T CELL CULTURE SUPERNATANTS OF PATIENTS WITH ACTIVE BEHCET'S DIS…

2004

Gramzyme A (GrA) is a serine proteinase with trypsin-like activity that is released extracellularly during the degranulation of cytotoxic cells. Among the cytotoxic cells, gamma/delta T cells participate in the early phases of the immune response and are known to express perforin and granzymes constitutively in agreement with their cytolytic pontential.GrA activity was detected using the synthetic substrate N-alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester in the plasma and supernatants of peripheral blood mononuclear cell cultured in the presence of Dimethylallyl pyrophosphate to obtain Vgamma9/Vdelta2 T cell expansion.Significantly high levels of GrA were found in the serum and supernat…

AdultMaleAdolescentDose-Response Relationship DrugBehcet SyndromeT-LymphocytesSerine EndopeptidasesReceptors Antigen T-Cell gamma-deltaMiddle AgedFlow CytometryGranzymesCulture Media ConditionedHumansFemaleCells CulturedAged
researchProduct

Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleuk…

2002

Behçet's disease is a multisystem disease in which there is evidence of immunological dysregulation. It has been proposed that gamma/delta T cells are involved in its pathogenesis. The aim of the present study was to assess the capacity of gamma/delta T cells with phenotype Vgamma9/Vdelta2, from a group of Italian patients with Behçet's disease, to proliferate in the presence of various phosphoantigens and to express tumour necrosis factor (TNF) and IL-12 receptors. Twenty-five patients and 45 healthy individuals were studied. Vgamma9/Vdelta2 T cells were analyzed by fluorescence activated cell sorting, utilizing specific monoclonal antibodies. For the expansion of Vgamma9/Vdelta2 T cells, …

AdultMaleBehçet's diseaseBehcet SyndromeT-LymphocytesReceptors Interleukin-12Receptors Antigen T-Cell gamma-deltaReceptors InterleukinMiddle AgedLymphocyte Activationγ/δ T lymphocyteReceptors Tumor Necrosis FactorPhenotypetumour necrosis factorItalyHumansFemaleinterleukin 12Cell DivisionCells CulturedResearch ArticleArthritis researchtherapy
researchProduct

Pentoxifylline Inhibits Vγ9/Vδ2 T Lymphocyte Activation of Patients with Active Behçet's Disease in Vitro

2007

The aim of this study is to evaluate the in vitro effect of pentoxifylline (PTX) on T Vgamma9/Vdelta2 lymphocyte function in Behçets disease (BD). We investigated the effect of PTX on Vgamma9/Vdelta2 T cell expansion and expression of TNFRII receptor and perforin content before and after PTX addition by means of FACS analysis lymphocyte cultures from patients with active and inactive BD and healthy subjects. The addition of PTX at a concentration of 1 mg/ml determined a significant inhibition of cell expansion, a down regulation of TNF receptor expression and inhibited the PMA-induced degranulation of perforin. Taken together these data indicate that PTX is capable of interfering with Vgamm…

AdultMaleCytoplasmPhosphodiesterase InhibitorsT-LymphocytesT cellLymphocyteImmunologyIn Vitro TechniquesPharmacologyLymphocyte ActivationPentoxifylline03 medical and health sciences0302 clinical medicineIn vivomedicineHumansReceptors Tumor Necrosis Factor Type IIImmunology and AllergyPentoxifyllineReceptorPharmacologybiologyPerforinChemistryBehcet SyndromeDegranulationReceptors Antigen T-Cell gamma-deltaFlow Cytometrymedicine.anatomical_structurePerforinCell culture030220 oncology & carcinogenesisLeukocytes Mononuclearbiology.proteinFemale030215 immunologymedicine.drugInternational Journal of Immunopathology and Pharmacology
researchProduct

Pathological implications of Th1/Th2 cytokine genetic variants in Behçet's disease: Data from a pilot study in a Sicilian population

2013

Cytokines act as pleiotropic polypeptides able to regulate inflammatory/immune responses and to provide important signals in physiological and pathological processes. Several cytokines (Th1, Th2, and Th17) seem to be involved in the pathophysiology of Behçet's disease, a chronic immune-mediated disease characterized by oral and genital lesions and ocular inflammation. Its individual susceptibility seems to be modulated by genetic variants in genes codifying these cytokines. Th1 and Th17 seem to be involved in the disease's active phases, and Th2 seems to affect the development or severity of the disease; however, contrasting data are reported. In this study, some genetic variants of the Th1…

AdultMaleGenotypePopulationPilot ProjectsBehcet's diseaseDiseaseBiologyPolymorphism Single NucleotideBiochemistryYoung AdultImmune systemTh1 and Th2 cytokines Immune imbalance Behc¸et’s disease Polymorphisms SusceptibilityGene FrequencyGenotypeGeneticsmedicineHumansSettore MED/05 - Patologia ClinicaeducationSicilyMolecular BiologyPathologicalEcology Evolution Behavior and SystematicsSettore MED/04 - Patologia Generaleeducation.field_of_studyBehcet SyndromeInterleukinsGenetic VariationGeneral MedicineMiddle Agedmedicine.diseaseHuman geneticsPathophysiologySettore MED/16 - ReumatologiaImmunologyFemale
researchProduct

Enhancement of endothelial cell E-selectin expression by sera from patients with active Behçet's disease: moderate correlation with anti-endothelial …

1999

We studied the in vitro E-selection expression of endothelial cells treated with sera from patients with Behcet's disease (BD) and factors (anti-endothelial cell antibodies, anti-neutrophil cytoplasmic antibodies, cytokines, and myeloperoxidase (MPO) that may contribute to adhesion molecule expression. A total of 21 patients with BD and 27 healthy controls were studied. In vitro E-selectin endothelial cell expression was investigated by ELISA after HUVEC incubation with sera or purified IgG from patients with BD and controls. Increased E-selectin expression was observed when endothelial cells were incubated with sera from patients with active disease or from patients with circulating anti-e…

AdultMaleNeutrophilsImmunologyCellIn Vitro TechniquesImmunoglobulin GAntibodies Antineutrophil CytoplasmicE-selectinmedicineImmunology and AllergyHumansCells CulturedAgedAutoantibodiesPeroxidasebiologyCell adhesion moleculeBehcet SyndromeAutoantibodyMiddle AgedMolecular biologyEndothelial stem cellmedicine.anatomical_structureMyeloperoxidaseImmunoglobulin GImmunologybiology.proteinCytokinesFemaleEndothelium VascularAntibodyE-SelectinClinical immunology (Orlando, Fla.)
researchProduct

Haematopoietic stem cell transplantation for vasculitis including Behçet's disease and polychondritis: a retrospective analysis of patients recorded …

2006

Objective: To evaluate the feasibility of haematopoietic stem cell transplantation (HSCT) in vasculitis. Methods: This is a retrospective analysis of patients who had received HSCT for vasculitic diseases and have been reported to the European League Against Rheumatism autoimmune disease or European Bone Marrow Transplantation ProMISe databases. Information about the disease and outcome was obtained by a questionnaire sent to the referring centres. Response of the disease to HSCT was defined as partial or complete responses according to the ability to reduce immunosuppression after HSCT. In addition, the Medline database was searched for reports on HSCT in patients with vasculitis. Results:…

AdultMaleReoperationVasculitisDatabases Factualmedicine.medical_treatmentMEDLINEImmunologyBehcet's diseasecomputer.software_genreTransplantation AutologousGeneral Biochemistry Genetics and Molecular BiologyRheumatologyimmune system diseasesRecurrencehemic and lymphatic diseasesmedicineImmunology and AllergyHumansTransplantation HomologousRetrospective StudiesImmunosuppression TherapyDatabasePolyarteritis nodosabusiness.industryBehcet SyndromeHematopoietic Stem Cell TransplantationRetrospective cohort studyImmunosuppressionmedicine.diseaseConnective tissue diseaseTransplantationExtended ReportEuropesurgical procedures operativeTreatment OutcomeFemalebusinessVasculitiscomputerCartilage DiseasesRheumatism
researchProduct

Prevalence of headache in patients with Behçet's disease without overt neurological involvement

2003

The aims of the present study were to evaluate the prevalence of headache and the frequency of different headache syndromes in patients with Behçet's Disease (BD) without neurological involvement and to investigate the relationship with other clinical, and behavioural variables. Twenty-seven BD patients and 27 control subjects underwent a validated semistructured questionnaire based on the International Headache Society criteria. Levels of anxiety and depression, disease activity, and current medication were collected. Headache occurred in 88.9% of BD patients. There was no difference in the prevalence of the different headache syndromes between BD patients and controls. Only migraine witho…

AdultMaleSelf-AssessmentBehçet's diseaseBehcet SyndromeHeadacheGeneral MedicineHealth SurveysTension-type headacheItalyPrevalenceHumansFemaleSettore MED/26 - NeurologiaNeurology (clinical)Nervous System DiseasesMigraine
researchProduct

NF-κB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins

2005

Objective To determine whether prolongation of the inflammatory reaction in patients with Behcet's disease (BD) is related to apoptosis resistance and is associated with the up-regulation of antiapoptotic factors. Methods The percentage of cell death was evaluated by flow cytometry in peripheral blood mononuclear cells from 35 patients with BD and 30 healthy volunteers. The expression levels of antiapoptotic factors and NF-κB regulatory proteins were measured using Western blotting and immunohistochemical analyses. To down-regulate NF-κB nuclear translocation, BD T lymphocytes were exposed in vitro to thalidomide and subjected to transfection with NF-κB small interfering RNA. Results Althou…

AdultMaleSmall interfering RNAProgrammed cell deathT-LymphocytesT cellImmunologyCASP8 and FADD-Like Apoptosis Regulating Proteinbcl-X ProteinApoptosisCaspase 3TransfectionCaspase 8RheumatologyHumansImmunology and AllergyMedicinePharmacology (medical)fas ReceptorRNA Small InterferingCells CulturedDose-Response Relationship Drugbusiness.industryBehcet SyndromeIntracellular Signaling Peptides and ProteinsNF-kappa BTransfectionFlow CytometryFas receptorThalidomideUp-Regulationmedicine.anatomical_structureGene Expression RegulationProto-Oncogene Proteins c-bcl-2ApoptosisImmunologyLeukocytes MononuclearCancer researchFemalebusinessArthritis & Rheumatism
researchProduct